Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative an

LUND, Sweden, Dec. 17, 2024 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), today announced positive full results from the 15-HMedIdeS-09 ... Read more

Bron:

Health